IRCT20210519051345N26尚未招募未知
In vivo fasted-state bioequivalence study of Fluoxetine 90 mg capsule manufactured by Omid Behbood Co. compared to innovator product
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 59 years（—）
- 性别
- Male
入选标准
- •General Health (in terms of Liver, Heart and Kidney)
排除标准
- •History of cardiovascular disease, liver and kidney disease
- •Alcohol and drug addiction
- •History of drug allergy
研究者
相似试验
招募中
Unknown
In vivo Bioequivalence study of Fexofenadine tabletIn the present study, the products will be administered to healthy volunteers..IRCT20220211053992N39Tabriz University of Medical Sciences24
尚未招募
不适用
Investigating the in vivo bioequivalence of Fexofenadine suspensioIn the present study, the products will be administered to healthy volunteers..IRCT20210519051345N24Tabriz University of Medical Sciences24
尚未招募
Unknown
In vivo Bioequivalence study of Famotidine tabletIRCT20220211053992N35Tabriz University of Medical Sciences24
招募中
Unknown
Bioequivalence study of Famotidine 40 mg tablet.IRCT20210519051345N39Tabriz University of Medical Sciences24
尚未招募
Unknown
In vivo Bioequivalence study of Levodopa/benserazide tabletsIRCT20220211053992N32Tabriz University of Medical Sciences24